Distinguishing nested variants of urothelial carcinoma from benign mimickers by TERT promoter mutation

Minghao Zhong, Wei Tian, Jian Zhuge, Xiaoyong Zheng, Tiangui Huang, Dongming Cai, David Zhang, Ximing J. Yang, Pedram Argani, John T. Fallon, Jonathan Ira Epstein

Research output: Contribution to journalArticle

Abstract

Nested variant of urothelial carcinoma (NVUC) is an uncommon variant with minimally atypical cytology, which may overlap with benign urothelial lesions such as von Brunn nests, cystitis cystica, cystitis glandularis, and nephrogenic adenoma. Because of the tumor's deceptively bland appearance, these cancers can potentially be misdiagnosed as benign lesions, leading in some cases to a significant delay in correct diagnosis and appropriate treatment. Prior studies suggest that Ki67 and p53 are useful markers in distinguishing NVUC from benign lesions. However, the overlap in the rates of immunoreactivity has prevented pathologists from using these markers as reliable adjunct markers in differentiating NVUC from mimickers. In addition, large nested variant urothelial carcinoma (LNVUC), a relatively new entity, shares features of both the NVUC and papillary urothelial carcinomas with an inverted growth pattern. They also mimic benign lesions, such as proliferation of von Brunn nests and inverted urothelial papilloma. With the recent demonstration of a strong association of TERT promoter mutations and urothelial carcinoma, we hypothesized that TERT promoter mutations would be a useful marker to distinguish NVUC and LNVUC from other benign urothelial lesions. We have therefore sequenced the TERT promoter region of 20 cases of NVUC, 10 cases of LNVUC, 5 cases of von Brunn nests, 3 cases of cystitis cystica, 3 cases of cystitis glandularis, and 3 cases of nephrogenic adenoma. We found that 17 of 20 cases of NVUC and 8 of 10 cases of LNVUC had TERT promoter mutation: C228T; no mutation was found in any of the benign mimickers (0/14). This result strongly suggests that TERT promoter mutation is a useful adjunct biomarker to distinguish NVUC and LNVUC from benign mimickers.

Original languageEnglish (US)
Pages (from-to)127-131
Number of pages5
JournalAmerican Journal of Surgical Pathology
Volume39
Issue number1
StatePublished - Jan 20 2015

Fingerprint

Carcinoma
Mutation
Cystitis
Adenoma
Inverted Papilloma
Papillary Carcinoma
Diagnostic Errors
Genetic Promoter Regions
Cell Biology
Neoplasms
Biomarkers
Growth

Keywords

  • Benign mimickers
  • Nested variants of urothelial carcinoma
  • TERT promoter mutation

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine
  • Surgery
  • Medicine(all)

Cite this

Distinguishing nested variants of urothelial carcinoma from benign mimickers by TERT promoter mutation. / Zhong, Minghao; Tian, Wei; Zhuge, Jian; Zheng, Xiaoyong; Huang, Tiangui; Cai, Dongming; Zhang, David; Yang, Ximing J.; Argani, Pedram; Fallon, John T.; Epstein, Jonathan Ira.

In: American Journal of Surgical Pathology, Vol. 39, No. 1, 20.01.2015, p. 127-131.

Research output: Contribution to journalArticle

Zhong, M, Tian, W, Zhuge, J, Zheng, X, Huang, T, Cai, D, Zhang, D, Yang, XJ, Argani, P, Fallon, JT & Epstein, JI 2015, 'Distinguishing nested variants of urothelial carcinoma from benign mimickers by TERT promoter mutation', American Journal of Surgical Pathology, vol. 39, no. 1, pp. 127-131.
Zhong, Minghao ; Tian, Wei ; Zhuge, Jian ; Zheng, Xiaoyong ; Huang, Tiangui ; Cai, Dongming ; Zhang, David ; Yang, Ximing J. ; Argani, Pedram ; Fallon, John T. ; Epstein, Jonathan Ira. / Distinguishing nested variants of urothelial carcinoma from benign mimickers by TERT promoter mutation. In: American Journal of Surgical Pathology. 2015 ; Vol. 39, No. 1. pp. 127-131.
@article{183f3550de06407187e9fe525c0e1176,
title = "Distinguishing nested variants of urothelial carcinoma from benign mimickers by TERT promoter mutation",
abstract = "Nested variant of urothelial carcinoma (NVUC) is an uncommon variant with minimally atypical cytology, which may overlap with benign urothelial lesions such as von Brunn nests, cystitis cystica, cystitis glandularis, and nephrogenic adenoma. Because of the tumor's deceptively bland appearance, these cancers can potentially be misdiagnosed as benign lesions, leading in some cases to a significant delay in correct diagnosis and appropriate treatment. Prior studies suggest that Ki67 and p53 are useful markers in distinguishing NVUC from benign lesions. However, the overlap in the rates of immunoreactivity has prevented pathologists from using these markers as reliable adjunct markers in differentiating NVUC from mimickers. In addition, large nested variant urothelial carcinoma (LNVUC), a relatively new entity, shares features of both the NVUC and papillary urothelial carcinomas with an inverted growth pattern. They also mimic benign lesions, such as proliferation of von Brunn nests and inverted urothelial papilloma. With the recent demonstration of a strong association of TERT promoter mutations and urothelial carcinoma, we hypothesized that TERT promoter mutations would be a useful marker to distinguish NVUC and LNVUC from other benign urothelial lesions. We have therefore sequenced the TERT promoter region of 20 cases of NVUC, 10 cases of LNVUC, 5 cases of von Brunn nests, 3 cases of cystitis cystica, 3 cases of cystitis glandularis, and 3 cases of nephrogenic adenoma. We found that 17 of 20 cases of NVUC and 8 of 10 cases of LNVUC had TERT promoter mutation: C228T; no mutation was found in any of the benign mimickers (0/14). This result strongly suggests that TERT promoter mutation is a useful adjunct biomarker to distinguish NVUC and LNVUC from benign mimickers.",
keywords = "Benign mimickers, Nested variants of urothelial carcinoma, TERT promoter mutation",
author = "Minghao Zhong and Wei Tian and Jian Zhuge and Xiaoyong Zheng and Tiangui Huang and Dongming Cai and David Zhang and Yang, {Ximing J.} and Pedram Argani and Fallon, {John T.} and Epstein, {Jonathan Ira}",
year = "2015",
month = "1",
day = "20",
language = "English (US)",
volume = "39",
pages = "127--131",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Distinguishing nested variants of urothelial carcinoma from benign mimickers by TERT promoter mutation

AU - Zhong, Minghao

AU - Tian, Wei

AU - Zhuge, Jian

AU - Zheng, Xiaoyong

AU - Huang, Tiangui

AU - Cai, Dongming

AU - Zhang, David

AU - Yang, Ximing J.

AU - Argani, Pedram

AU - Fallon, John T.

AU - Epstein, Jonathan Ira

PY - 2015/1/20

Y1 - 2015/1/20

N2 - Nested variant of urothelial carcinoma (NVUC) is an uncommon variant with minimally atypical cytology, which may overlap with benign urothelial lesions such as von Brunn nests, cystitis cystica, cystitis glandularis, and nephrogenic adenoma. Because of the tumor's deceptively bland appearance, these cancers can potentially be misdiagnosed as benign lesions, leading in some cases to a significant delay in correct diagnosis and appropriate treatment. Prior studies suggest that Ki67 and p53 are useful markers in distinguishing NVUC from benign lesions. However, the overlap in the rates of immunoreactivity has prevented pathologists from using these markers as reliable adjunct markers in differentiating NVUC from mimickers. In addition, large nested variant urothelial carcinoma (LNVUC), a relatively new entity, shares features of both the NVUC and papillary urothelial carcinomas with an inverted growth pattern. They also mimic benign lesions, such as proliferation of von Brunn nests and inverted urothelial papilloma. With the recent demonstration of a strong association of TERT promoter mutations and urothelial carcinoma, we hypothesized that TERT promoter mutations would be a useful marker to distinguish NVUC and LNVUC from other benign urothelial lesions. We have therefore sequenced the TERT promoter region of 20 cases of NVUC, 10 cases of LNVUC, 5 cases of von Brunn nests, 3 cases of cystitis cystica, 3 cases of cystitis glandularis, and 3 cases of nephrogenic adenoma. We found that 17 of 20 cases of NVUC and 8 of 10 cases of LNVUC had TERT promoter mutation: C228T; no mutation was found in any of the benign mimickers (0/14). This result strongly suggests that TERT promoter mutation is a useful adjunct biomarker to distinguish NVUC and LNVUC from benign mimickers.

AB - Nested variant of urothelial carcinoma (NVUC) is an uncommon variant with minimally atypical cytology, which may overlap with benign urothelial lesions such as von Brunn nests, cystitis cystica, cystitis glandularis, and nephrogenic adenoma. Because of the tumor's deceptively bland appearance, these cancers can potentially be misdiagnosed as benign lesions, leading in some cases to a significant delay in correct diagnosis and appropriate treatment. Prior studies suggest that Ki67 and p53 are useful markers in distinguishing NVUC from benign lesions. However, the overlap in the rates of immunoreactivity has prevented pathologists from using these markers as reliable adjunct markers in differentiating NVUC from mimickers. In addition, large nested variant urothelial carcinoma (LNVUC), a relatively new entity, shares features of both the NVUC and papillary urothelial carcinomas with an inverted growth pattern. They also mimic benign lesions, such as proliferation of von Brunn nests and inverted urothelial papilloma. With the recent demonstration of a strong association of TERT promoter mutations and urothelial carcinoma, we hypothesized that TERT promoter mutations would be a useful marker to distinguish NVUC and LNVUC from other benign urothelial lesions. We have therefore sequenced the TERT promoter region of 20 cases of NVUC, 10 cases of LNVUC, 5 cases of von Brunn nests, 3 cases of cystitis cystica, 3 cases of cystitis glandularis, and 3 cases of nephrogenic adenoma. We found that 17 of 20 cases of NVUC and 8 of 10 cases of LNVUC had TERT promoter mutation: C228T; no mutation was found in any of the benign mimickers (0/14). This result strongly suggests that TERT promoter mutation is a useful adjunct biomarker to distinguish NVUC and LNVUC from benign mimickers.

KW - Benign mimickers

KW - Nested variants of urothelial carcinoma

KW - TERT promoter mutation

UR - http://www.scopus.com/inward/record.url?scp=84919400533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919400533&partnerID=8YFLogxK

M3 - Article

VL - 39

SP - 127

EP - 131

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 1

ER -